Publication dates

Gene Therapy Industry, September 2014 Market Reports from Top Publishers

You might be interested in: hemophilia, cancer, medical equipment, more »


 
1-10 of 35 reports for Gene Therapy

Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Opthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter opthalmics partnering deals. The majority of deals are discovery, preclinical ...

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... Material into cells. The company's technologies are focused on broad range of areas like gene modulation, gene therapy, cell therapy, protein therapy and genetic vaccines. The company partnered with dr ...

Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Medica Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2014
  • by Global Data

... Across 17 centres in the uk. The company has collaboration with the center for cell and gene therapy at baylor college of medicine. Cell medica is headquartered in london, england, the uk ...

Gene Therapy in Oncology Drug Pipeline Update 2014

Gene Therapy in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... Suspended drugs and the accumulated number of ceased drugs over the last years amount to another 97 drugs. gene therapy in oncology drug pipeline update lists all drugs and gives you a progress analysis ...

Integrase Inhibitors -Pipeline Insights, 2014

Integrase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Integrase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2

Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2

  • $ 4 650
  • Industry report
  • July 2014
  • by MarketsandMarkets

... Of fields. On the basis of application, the report is segmented into biopharmaceutical production, cancer research, drug screening and development, gene therapy, tissue culture and engineering, toxicity ...

Physician Views: Are neurologists ready to embrace gene therapy?

Physician Views: Are neurologists ready to embrace gene therapy?

  • $ 645
  • Industry report
  • June 2014
  • by Firstword Pharma

... Around the commercial opportunity of these products.Parkinson's disease - an area bereft of significant clinical breakthroughs in recent years - has emerged as a focal point for a handful of gene ...

Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Benitec Biopharma Limited (Benitec), formerly Benitec Limited, is a research focused biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening ...

Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • May 2014
  • by Currentpartnering

... Including over 300 links to online deal records of actual gene therapy partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted ...

Bone Regeneration - Pipeline Review, H1 2014

Bone Regeneration - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • April 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H1 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...

About 600 reports for Gene Therapy

Download Unlimited Documents from Trusted Public Sources

Global Gene Therapy Markets - Forecast

  • Bio Industry
  • February 2012
    48 pages
  • Dna  

    Molecular Diagn...  

    Gene Therapy  

  • United States  

    South Korea  

    World  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.